41
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T28001 |
MDK-6983
MDK-6983,Compound 6k,Autophagy inhibitor 6k,MDK6983 |
Autophagy | Autophagy |
MDK-6983 (MDK-6983) 是一种自噬抑制剂,可破坏人黑色素瘤细胞中肌动蛋白细胞骨架的动力学。 | |||
T19765 |
MDK-4025
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
MDK-4025 是锥体神经元中高压激活 (HVA) Ca2+ 电流的抑制剂。 | |||
T5310 |
TR-14035
MDK-1191 |
Integrin | Cytoskeletal Signaling |
TR-14035 (MDK-1191) 是一种具有口服活性的 α4β7/α4β1整合素双重抑制剂,对 α4β7和 α4β1作用的 IC50值分别为 7 和 87 nM,可用于炎症和自体免疫疾病的研究。 | |||
T25779 |
MDK-4683
MDK 4683,CA IX/XII Inhibitor |
||
MDK-4683, also known as CA IX/XII Inhibitor, is a hCA IX and hCA XII inhibitor. | |||
T33261 |
MDK-5432
AMPA stabilizer (R,R)-2a,MDK 5432 |
||
MDK-5432, also known as AMPA stabilizer (R,R)-2a, is the most potent AMPA stabilizer. | |||
T25780 |
MDK-4823
LMPTP-IN-23,LMPTP-IN 23,MDK4823,LMPTP-IN23,MDK 4823 |
||
MDK-4823, also known as LMPTP inhibitor1, is a potent low-molecular-weight tyrosine phosphatase (LMPTP) inhibitor. LMPTP is highly expressed in insulin-target tissues. LMPTP promotes diabetes and insulin resistance in obesity. | |||
T27998 |
MDK-4204
Anticancer AgentI,MDK 4204,Anticancer Agent I,MDK4204,Anticancer Agent-I |
||
MDK-4204, an anticancer agent, shows significant anti-cancer activity with IC50 values of 8.8 µM and 9.5 µM in PC-3 and DU-145 cells, respectively. | |||
T27997 |
MDK-3345
MDK 3345,Mcl-1 Inhibitor11,Mcl-1 Inhibitor 11,Mcl-1 Inhibitor-11 |
||
MDK-3345 is a reversible covalent inhibitor for Mcl-1. | |||
T5093 |
Pim1/AKK1-IN-1
LKB1/AAK1 dual inhibitor,MDK-2275 |
Pim; Hippo pathway | Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
Pim1/AKK1-IN-1 (LKB1/AAK1 dual inhibitor) 是多种酶抑制剂,能够作用于Pim1、AKK1、MST2 和 LKB1,Kd 值分别为 35、53、75 和 380 nM,还抑制 MPSK1 和 TNIK。 | |||
T9033 |
BTYNB
MDK6620,BTYNB IMP1 Inhibitor |
Others; c-Myc; NF-κB | Cell Cycle/Checkpoint; NF-κB; Others |
BTYNB (MDK6620) 是IMP1结合 c-Myc mRNA 的有效选择性抑制剂,IC50为 5 μM。它下调 β-TrCP1 mRNA 并减少NF-κB 的激活。它通过损害 IGF2 mRNA 结合蛋白 1 结合来破坏这种增强子功能,可用于癌症研究。 | |||
T8412 |
(S,R,S)-AHPC
VH032-NH2,MDK7526,VHL ligand 1 |
Others; Ligand for E3 Ligase | Others; PROTAC |
(S,R,S)-AHPC (VH032-NH2) 是一种 VH032-based VHL ligand,可用于募集 von Hippel-Lindau (VHL)蛋白。它能够利用 linker 与靶蛋白配体连接,得到 PROTAC 分子。 | |||
T27991 |
MDK-0757
Hsp90-IN-89,MDK0757 |
||
MDK-0757 is a novel inhibitor of heat shock protein 90 (Hsp90). | |||
T27995 |
MDK-3046
HK-inhibitor-2,MDK3046,HK inhibitor 2 |
||
MDK-3046 is a YycG histidine kinase (HK) inhibitor with potent antibiofim activity against Staphylococcus epidermidis. | |||
T27990 |
MDK-0738
AKR1C3-IN-14a,AKR1C3 IN 14a |
||
MDK-0738 is a potent and selective aldo-keto reductase 1C3 inhibitor. | |||
T27999 |
MDK-4624
AMPKα1 activator C13,C13, Compound 13 |
||
MDK-4624 is a AMPKα1 activator. MDK-4624 inhibits Helicobacter pylori-induced oxidative stresses and gastric epithelial cell apoptosis. MDK-4624 attenuates dexamethasone-induced osteoblast cell death. MDK-4624 potently inhibits melanoma cell proliferation | |||
T27994 |
MDK-2959
PTPsigma inhibitor2,PTPsigma inhibitor 2,PTPsigmainhibitor2 |
||
MDK-2959 is a potent inhibitor of protein tyrosine phosphatase sigma (PTPsigma). | |||
T27996 |
MDK-3298
Mcl-1 Inhibitor-5,Mcl-1 Inhibitor 5,MDK3298,Mcl-1 Inhibitor5 |
||
MDK-3298 is a reversible covalent inhibitor of Mcl-1, a target of protein-protein interaction (PPI). | |||
T27992 |
MDK08445
MDK-08445,MDK 08445 |
||
MDK08445 is an important intermediate or precursor for the synthesis of Cefiderocol, a potent siderophore cephalosporin antibiotic. | |||
T28000 |
MDK49781
MDK-49781,MDK 49781 |
||
MDK49781 is a useful chemical intermediate for drug synthesis. | |||
T28004 |
MDK8228
PF-CBP/BRD4,MDK-8228,MDK 8228 |
||
MDK8228 is an inhibitor of CBP/p300 and BRD4 bromodomain. MDK8228 downregulates IL-6, IL-ß and IFN-ß in macrophages. | |||
T1772 |
MDK83190
Apoptosis Activator 2 |
Apoptosis; Caspase | Apoptosis; Proteases/Proteasome |
MDK83190 (Apoptosis Activator 2) 是一种细胞凋亡激活剂,可诱导 caspase-3 激活、Apaf-1 寡聚化、PARP 切割和 DNA 片段化。 | |||
T28002 |
MDK71803
MDK-71803,Cefiderocol-intermediate, Cefiderocol-precursor,MDK 71803 |
||
MDK71803 is an important intermediate or precursor for the synthesis of Cefiderocol, a potent siderophore cephalosporin antibiotic with a catechol moiety on the 3-position side chain. | |||
T24438 |
MDK5466
MDK-5466,MDK 5466,E21,Flt3-IN-III,Flt3 Inhibitor III |
||
MDK5466 is an Flt3 inhibitor that acts by preventing glutamate-induced cell death. | |||
T70601 |
MDK03855
|
||
MDK03855, also known as A2AR antagonist 19, is an adenosine A2A receptor (A2AR) antagonist. MDK03855 has CAS#1454903-85-5. The last five digit of CAS# was used for name. | |||
T70141 | MDK80908 | ||
MDK80908, also known as PPARalpha/gamma agonist N15, is a dual PPARα/γ agonist, ameliorating insulin resistance and gluconeogenesis in vivo and vitro. MDK80908 has CAS#1821380-90-8. | |||
T70069 |
MDK6465
|
||
MDK6465, also known as PCSK9-IN-8b, is a novel liver-targeted inhibitor of ribosomal synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9). MDK6465 has CAS#1900686-46-5. the last 4 digits are used in its name. | |||
T28003 |
MDK7677
Cathepsin B Inhinitor-17,MDK 7677 |
||
MDK7677 is a selective inhibitor of cathepsin B endopeptidase and exopeptidase activities. | |||
T69916 |
MDK3673
|
||
MDK3673, also known as Olfr895-Agonist-10, is a novel specific agonist of odorant receptor 895 (Olfr895). | |||
T9460 |
iMDK
|
PI3K | PI3K/Akt/mTOR signaling |
iMDK 是PI3K 抑制剂,能够抑制生长因子MDK。它能够与 MEK 抑制剂协同抑制非小细胞肺癌,而不会伤害正常细胞和小鼠。 | |||
T16529 |
BEBT-908
PI3Kα inhibitor 1,MDK9521 |
PI3K; HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
BEBT-908 (PI3Kα inhibitor 1) 是一种选择性的PI3Kα抑制剂(IC50<0.1 μM),也抑制 HDAC (0.1 μM≤IC50≤1 μM)。 | |||
T27989 |
MDK0734
Cathepsin B Inhinitor-42 |
||
MDK0734 is a selective inhibitor of cathepsin B endopeptidase and exopeptidase activities. | |||
T70599 | Asem F-18 | ||
Asem F-18 is a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET . | |||
T69915 |
GX-585
|
||
GX-585 is a novel potent inhibitor of NaV1.7 and highly selective against NaV1.5, having limited selectivity against NaV1.1 and NaV1.2. | |||
T70068 |
AT-1015 hydrochloride monohydrate
|
||
AT-1015 hydrochloride monohydrate is a serotonin (5-HT)2 receptor antagonist that blocks vascular and platelet 5-HT2A receptors. | |||
T68559 |
OUN58101
|
||
OUN58101, also known as MDK-8101, also known as BI-D, is a RSV L-protein inhibitor. OUN58101 was first reported in patnet WO 2005042530. This product has no formal name at the moment. For the convenience of communication, a temporal code name was therefore proposed according to MedKoo Chemical Nomenclature (see web page: https://www.medkoo.com/page/naming). | |||
T3190 |
PIK-inhibitors
MDK34597 |
PI3K | PI3K/Akt/mTOR signaling |
PIK-inhibitors (MDK34597) 是一种泛 PI3K 抑制剂,是 PI-103 的类似物。 | |||
T70140 |
D 22888
|
||
D 22888 is a PDE4 inhibitor. | |||
T4198 |
T.cruzi-IN-1
MDK1088,T.cruzi Inhibitor |
Antibiotic; Parasite | Microbiology/Virology |
T.cruzi-IN-1 (MDK1088) 是一种克氏锥虫抑制剂,IC50为 8 nM。它是一种 4-三氟甲基取代的类似物,有潜力治疗南美锥虫病的急性和慢性阶段。 | |||
T24439 |
MDK6204
CLK1/2 IN 2,CLK1/2IN2,CLK1/2-inhibitor-2,CLK1/2-IN-2,CLK1/2 inhibitor 2 |
||
MDK6204 is a selective inhibitor of CLK1 and CLK2. | |||
T61627 | iMDK quarterhydrate | ||
iMDK quarterhydrate, a potent PI3K inhibitor, is effective in inhibiting the growth factor MDK (also known as midkine or MK) while demonstrating suppression of non-small cell lung cancer (NSCLC). In combination with a MEK inhibitor, iMDK quarterhydrate demonstrates cooperative inhibition of NSCLC without causing harm to normal cells and mice [1]. | |||
T7082 |
HDAC8-IN-1
|
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
HDAC8-IN-1 是一种 HDAC8 抑制剂,在癌细胞系中的 IC50 为 27.2 nM,有抗增殖作用。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-00024 |
Midkine Protein, Human, Recombinant (His & Avi), Biotinylated
MK1,MK,MDK,NEGF2,MKARAP,MEK,ARAP |
Human | E. coli |
Midkine is a heparin-binding growth factor, originally reported as the product of a retinoic acid-responsive gene during embryogenesis, but currently viewed as a multifaceted factor contributing to both normal tissue homeostasis and disease development. Midkine is abnormally expressed at high levels in various human malignancies and acts as a mediator for the acquisition of critical hallmarks of cancer, including cell growth, survival, metastasis, migration, and angiogenesis. Midkine Protein, Hu... | |||
TMPK-00023 |
Midkine Protein, Human, Recombinant (His & Avi)
MDK,MEK,MK1,MKARAP,ARAP,MK,NEGF2 |
Human | E. coli |
Midkine is a heparin-binding growth factor, originally reported as the product of a retinoic acid-responsive gene during embryogenesis, but currently viewed as a multifaceted factor contributing to both normal tissue homeostasis and disease development. Midkine is abnormally expressed at high levels in various human malignancies and acts as a mediator for the acquisition of critical hallmarks of cancer, including cell growth, survival, metastasis, migration, and angiogenesis. Midkine Protein, Hu... | |||
TMPK-00812 |
Midkine Protein, Mouse, Recombinant (His)
MK1,ARAP,MKARAP,MEK,MK,NEGF2,MDK |
Mouse | E. coli |
Midkine is a heparin-binding growth factor, originally reported as the product of a retinoic acid-responsive gene during embryogenesis, but currently viewed as a multifaceted factor contributing to both normal tissue homeostasis and disease development. Midkine is abnormally expressed at high levels in various human malignancies and acts as a mediator for the acquisition of critical hallmarks of cancer, including cell growth, survival, metastasis, migration, and angiogenesis. Midkine Protein, Mo... | |||
TMPY-01786 |
EphB4 Protein, Mouse, Recombinant (hFc)
MDK2,Htk,Myk1,AI042935,Tyro11,EPH receptor B4 |
Mouse | HEK293 Cells |
EphB4 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 84.7 kDa and the accession number is P54761-1. | |||
TMPY-01787 |
EphB4 Protein, Mouse, Recombinant (His)
Myk1,Htk,Tyro11,MDK2,AI042935,EPH receptor B4 |
Mouse | HEK293 Cells |
EphB4 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 59 kDa and the accession number is P54761-1. | |||
TMPY-01784 |
EphB3 Protein, Mouse, Recombinant (His)
MDK5,Tyro6,Etk2,HEK2,EPH receptor B3,Cek10,Sek4,AW4... |
Mouse | HEK293 Cells |
EphB3 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 57 kDa and the accession number is P54754. | |||
TMPK-00898 |
EphB3 Protein, Human, Recombinant (His)
EC 2.7.10.1,EPHB3,ETK2,EK2,HEK2,AW456895,Sek4,MDK5,... |
Human | HEK293 Cells |
Although EphB3 expression is down-regulated in colorectal cancer (CRC) cells compared with normal intestinal epithelial cells.EphB3 is down-regulated in CRC compared to normal mucosa. Hypermethylation of CpG island is contributed to downregulation of EphB3 in CRC. EphB3 expression in tumor cells may be a useful prognostic indicator for patients with CRC. | |||
TMPY-02172 |
Midkine Protein, Human, Recombinant
midkine (neurite growth-promoting factor 2),NEGF2,MK,ARAP |
Human | Baculovirus Insect Cells |
Midkine (MK or MDK) also known as neurite growth-promoting factor 2 (NEGF2) is a basic heparin-binding growth factor of low molecular weight, and forms a family with pleiotrophin. Midkine is a retinoic acid-responsive, heparin-binding growth factor expressed in various cell types during embryogenesis. It promotes angiogenesis, cell growth, and cell migration. Midkine is also expressed in several carcinomas, suggesting that it may play a role in tumorigenesis, perhaps through its effects on angio... |